AnBio Therapeutics Ltd. — Form D

AnBio Therapeutics Ltd. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2021-10-13. The offering totals $60.9M, of which $60.9M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2021-10-13
• Form: D
• Accession: 0001887703-21-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $60.9M
• Amount sold: $60.9M
• Minimum investment: $200K
• Investors: 13
• Date of first sale: 2021-09-24
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-416641

Issuer

• Name: AnBio Therapeutics Ltd.
• CIK: 0001887703
• Entity type: Corporation
• Jurisdiction: CAYMAN ISLANDS
• Incorporated: 2021
• Address: 777 THIRD AVENUE, SUITE 1704, NEW YORK, NY, 10017
• Phone: 212-466-6378

Officers, directors & promoters (10)

More

• CIK 1887703 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search